Resistin, Adiponectin, and Risk of Heart Failure: The Framingham Offspring Study
- 3 March 2009
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 53 (9), 754-762
- https://doi.org/10.1016/j.jacc.2008.07.073
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Total and High–Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program: Comparative Evaluation of Three AssaysDiabetes Care, 2007
- Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetesCytokine, 2006
- Circulating adiponectin concentrations in patients with congestive heart failureHeart, 2006
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Associations Between Serum Resistin Levels and Insulin Resistance, Inflammation, and Coronary Artery DiseaseJournal of the American College of Cardiology, 2005
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathThe New England Journal of Medicine, 2004
- Obesity and Systemic Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Reciprocal Association of C-Reactive Protein With Adiponectin in Blood Stream and Adipose TissueCirculation, 2003
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsThe New England Journal of Medicine, 1999